R-FCM protocol

Preferred Label : R-FCM protocol;

MeSH note : chemotherapy protocol consisting of rituximab, fluddarabine, cyclophosphamide, and mitoxanthrone for treatment of mantle cell lymphoma;

Is substance : O;

Détails

Origin ID

C518738;

UMLS CUI

C1871911;

Currated CISMeF NLP mapping
- R-FCM Regimen [NCIt concept]
MeSH term(s) associated for indexing
- Rituximab [MeSH Descriptor]
- antibodies, monoclonal, Murine-Derived [MeSH Descriptor]
- antineoplastic combined chemotherapy protocols [MeSH Descriptor]
- cyclophosphamide [MeSH Descriptor]
- mitoxantrone [MeSH Descriptor]
- vidarabine [MeSH Descriptor]
Record concept(s)
- R-FCM protocol [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
UMLS correspondences (same concept)
- R-FCM Regimen [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients